Chemours (NYSE:CC) tumbled 10% in extended trading Tuesday after the chemical maker reported a net loss for the first quarter ...

Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings. Read more to see why CC ...

Rep. Ted Davis has spent five years working on legislation that would make Chemours pay for PFAS-removing upgrades built by ...

Q1 2025 Earnings Call Transcript May 7, 2025 Operator: Good morning. My name is Michelle, and I will be your conference ...

The Chemours Co (CC) reports a mixed quarter with strategic expansions and a significant dividend reduction amid financial ...

Recently, Chemours, a global chemistry company, announced a strategic agreement with Navin Fluorine International Limited (Navin Fluorine) to manufacture its Opteon™ two-phase immersion cooling ...

The Chemours Company reported strong Opteon refrigerant sales growth and outlined strategic initiatives to navigate regulatory challenges and market volatility. Adjusted EBITDA guidance for 2025 ...

After years of efforts to pass similar legislation, Rep. Ted Davis successfully spearheaded a bill to make Chemours liable ...

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 19 cents per share. The chemical company posted ...

Eight years after the general public found out about PFAS in the Cape Fear River, the North Carolina House has finally passed ...

Chemours may need to reimburse southeastern North Carolina utilities for hundreds of millions of dollars in filtration technology, under legislation the N.C. House of Representatives passed nearly ...

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, announced a strategic agreement with Navin Fluorine International Limited (Navin Fluorine) (NSE: NAVINFLUOR) to manufacture its ...